Literature DB >> 22460165

Osteoarthritis: Virtual joint replacement as an outcome measure in OA.

David T Felson.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22460165     DOI： 10.1038/nrrheum.2012.34

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  5 in total

Review 1.  Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria.

Authors:  Thao Pham; Désirée Van Der Heijde; Marissa Lassere; Roy D Altman; Jennifer J Anderson; Nicholas Bellamy; Marc Hochberg; Lee Simon; Vibeke Strand; Thasia Woodworth; Maxime Dougados
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

2.  The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement.

Authors:  L Gossec; S Paternotte; J F Maillefert; C Combescure; P G Conaghan; A M Davis; K-P Gunther; G Hawker; M Hochberg; J N Katz; M Kloppenburg; K Lim; L S Lohmander; N N Mahomed; L March; K Pavelka; L Punzi; E M Roos; L Sanchez-Riera; J A Singh; M E Suarez-Almazor; M Dougados
Journal:  Osteoarthritis Cartilage       Date:  2010-10-31       Impact factor: 6.576

3.  The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis.

Authors:  Shreyasee Amin; Michael P LaValley; Ali Guermazi; Mikayel Grigoryan; David J Hunter; Margaret Clancy; Jingbo Niu; Daniel R Gale; David T Felson
Journal:  Arthritis Rheum       Date:  2005-10

4.  Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group.

Authors:  P G Conaghan; D J Hunter; J F Maillefert; W M Reichmann; E Losina
Journal:  Osteoarthritis Cartilage       Date:  2011-03-23       Impact factor: 6.576

5.  OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials.

Authors:  R L Manno; C O Bingham; S Paternotte; L Gossec; H Halhol; G Giacovelli; L Rovati; S A Mazzuca; D O Clegg; H Shi; E Tajana Messi; A Lanzarotti; M Dougados
Journal:  Osteoarthritis Cartilage       Date:  2011-11-28       Impact factor: 6.576
  5 in total
  1 in total

1.  Synovial fluid fingerprinting in end-stage knee osteoarthritis: a novel biomarker concept.

Authors:  Chethan Jayadev; Philippa Hulley; Catherine Swales; Sarah Snelling; Gary Collins; Peter Taylor; Andrew Price
Journal:  Bone Joint Res       Date:  2020-10-12       Impact factor: 5.853
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.